Expanding the impact of malaria chemoprevention

September 10, 2025 by PATH

With new approaches like seasonal and perennial malaria chemoprevention, and the opportunity to integrate with vaccines and other emerging tools, we're entering a new phase in malaria prevention. Recent research and country experience have shown what's possible — but scaling impact requires overcoming key challenges in policy, and financing, and delivery.

This webinar will explore the future of malaria chemoprevention: how strategies are evolving, what we're learning from implementation, and what's needed to deliver these tools more widely and equitably.

Please note that simultaneous French interpretation will be available.

SPEAKERS:

Dr. Caroline Phiri-Chibawe, Deputy Senior Technical Advisor for PMI Reach Malaria, PATH

Dr. Jane Achan, Principal Advisor, Malaria Consortium

Dr. Roly Gosling, Professor of Global Health, The London School of Hygiene & Tropical Medicine

Dr. Junior Voundi Voundi, Head of Malaria Chemoprevention, National Malaria Control Program of Cameroon

GSK logo with text

Join the conversation

View all past and upcoming PATH Live Forums

PATH Live Forums are curated live conversations with experts from PATH and our partners, with plenty of time for your questions.

Explore the Forums